ENTITY
Shanghai Medicilon

Shanghai Medicilon (688202 CH)

55
Analysis
Health CareChina
Shanghai Medicilon Inc. develops pharmaceutical products. The Company produces acquired immune deficiency syndrome drugs, anticancer drug sensitizers, genetic engineering vaccines, biomedical intermediates, and other products. Shanghai Medicilon also provides biological analysis, drug safety evaluation, and other services.
more
11 Nov 2022 12:32

Shanghai/​​​​​​​​​​​​​​​​​​​​Shenzhen Northbound Connect: Weekly Moves (11 November 2022)

Overall, net inflow over the past week in the HK -Shanghai-Shenzhen Northbound Connect facilities was ~US$0.26bn, split between Shanghai...

Logo
380 Views
Share
bullishSICC
25 Oct 2022 04:50

STAR50 Index Rebalance Preview: Stable Long/Short Performance in a Volatile Market

We expect the index committee to continue using a 6-month minimum listing history. That means 5 changes in December. The potential adds have...

Logo
535 Views
Share
13 Sep 2022 01:25

STAR50 Index Rebalance Preview: Four or Five Changes in December

There could be 4/5 changes if a 12/6 month minimum listing history is used. Using a 6 month minimum listing history, one-way turnover is estimated...

Logo
486 Views
Share
27 Aug 2022 09:34

STAR50 Index Rebalance: Adds Continue to Outperform as Changes Are Announced

There are 5 changes to the STAR50 in September as the index committee sticks to a 6 month minimum listing history. The adds have outperformed the...

Logo
569 Views
Share
20 Jul 2022 05:13

STAR50 Index Rebalance Preview (Sep): Adds Outperforming the Deletes

There could be 5 changes if the index committee continues using a 6 month minimum listing history. The adds have outperformed the deletes over the...

Logo
532 Views
Share
x